Koers Aerie Pharmaceuticals, Inc.
Aandelen
AERI
US00771V1089
Farmaceutische producten
Managers | Titel | Leeftijd | Van |
---|---|---|---|
David Endicott
CEO | Chief Executive Officer | 58 | 21-11-22 |
Andrew Allen
CMP | Compliance Officer | - | - |
Chief Tech/Sci/R&D Officer | - | 01-03-22 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Ian Bell
BRD | Director/Board Member | 54 | 21-11-22 |
Chairman | 57 | 21-11-22 | |
Jonathan Balch
BRD | Director/Board Member | - | 21-11-22 |
Naam | Gewicht | Volume | Vaira. 1 jan. | belegger rating |
---|---|---|---|---|
0.02% | 509 M€ | -.--% |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+25,61% | 660 mld. | |
+25,87% | 562 mld. | |
-5,24% | 358 mld. | |
+16,49% | 322 mld. | |
+8,28% | 297 mld. | |
+7,09% | 219 mld. | |
-9,12% | 196 mld. | |
+5,01% | 199 mld. | |
-8,75% | 149 mld. |